Defining the ideal properties of a moisture protective, instant release film coating - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Defining the ideal properties of a moisture protective, instant release film coating


Pharmaceutical Technology Europe
Volume 21, Issue 10

Many APIs are moisture-sensitive and thus need protection against ambient moisture. Usually, packaging materials are employed that provide a tight enclosure, but this adds costs to the already expensive manufacturing process. A more cost-effective alternative is to use well-formulated moisture protective coatings that reduce water vapour transmission rate (WVTR).


Stockbyte/Getty Images
We investigated polymer characteristics that provide efficient moisture protection and demonstrate— though it may seem contradictory— that adequate reduction of WVTR is possible with film coats based on a water-soluble polymer. For this, we compared the polymer types most often used in moisture protection1 : Hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol (PVA), and Kollicoat Instant Release (IR) combined with PVA (Kollicoat Protect; BASF, Germany).

Physical characteristics

WVTR can be described using Fick's first law,2 which states that the amount of water vapour diffusing across a film barrier at a given time is a function of the following:
  • The moisture gradient, which can be calculated based on the specific water activity of the core formulation and the ambient humidity. Whereas ambient humidity is defined by ICH guidelines (at least for stability studies),3 the water activity of the core is dependent on the excipients present in the core formulation.
  • The diffusion constant and the surface area of the tablet.
  • The layer thickness of the film.

To prevent free diffusion of water molecules across the film membrane, water-insoluble additives, such as pigments, can be incorporated into the coating formulation.4,5

The effect of this is prolonged diffusion time and distance within the core, which helps protect against moisture. A crucial polymer characteristic for this method of moisture protection is the flexibility of the polymer film; it must allow the incorporation of large amounts of water-insoluble pigments without negatively affecting the film strength and flexibility.

Preparing the polymers

To compare the characteristics of different polymers, we first prepared 20% polymer solutions, which were then cast as films on a Coatmaster (Erichsen, Germany) The cast films were left to acclimatise at 23 C/50% relative humidity (RH)6 for at least 48 h. Film strips with a 4 mm diameter were cut out using a manual punch, care being taken not to transfer moisture from the fingers to the film.

The cross section of the film was calculated based on the film thickness and width to calculate the strain. A self programmed Excel macro was then used to compute values obtained. The following elongation at break values were obtained for the polymers used: HPMC (3cP-grade: 3%; 6cP-grade: 11%), PVA (226%) and Kollicoat Protect (256%).6

Comparing the WVTR of different polymers

One method of determining the effectiveness of a moisture protective coating is by measuring the WVTR of the polymer films.

Moisture protection formulations based on HPMC, (incorporating stearic acid for moisture protection), PVA and Kollicoat Protect were prepared, and cast directly onto a PVC layer placed on a heatable metal plate. Typically, film coating processes are performed with an inlet air temperature of 50–80 C resulting in product temperatures of 35–45 C,6,7 so the cast films were dried at 45 C.


Figure 1: WVTR of different film coating formulations (23C/85% RH).
WVTR of the formulations was measured using a permeation moisture vapour transmission rate tester (Permatran-C model 4/41; Mocon, MN, USA). The results obtained were compared with a classical instant release coating formulation based on HPMC (not containing stearic acid that would reduce WVTR). Figure 1 shows the values obtained for the different moisture barrier formulations.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology Europe,
Click here